The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement / Cox, Tm; Aerts, Jm; Andria, Generoso; Beck, M; Belmatoug, N; Bembi, B; Chertkoff, R; VOM DAHL, S; Elstein, D; Erikson, A; Giralt, M; Heitner, R.. - In: JOURNAL OF INHERITED METABOLIC DISEASE. - ISSN 0141-8955. - 26:(2003), pp. 513-26.

The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement

ANDRIA, GENEROSO;
2003

2003
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement / Cox, Tm; Aerts, Jm; Andria, Generoso; Beck, M; Belmatoug, N; Bembi, B; Chertkoff, R; VOM DAHL, S; Elstein, D; Erikson, A; Giralt, M; Heitner, R.. - In: JOURNAL OF INHERITED METABOLIC DISEASE. - ISSN 0141-8955. - 26:(2003), pp. 513-26.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/153500
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact